News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Atherotech Diagnostics Lab Release: VAP Test Improves Identification of CIMT Progression



1/26/2012 9:27:17 AM

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Expanded cholesterol assessment of moderate risk patients can play an important role in identifying and monitoring the progression of atherosclerosis. That’s according to a clinical study that used the VAP® (Vertical Auto Profile) Cholesterol Test to analyze lipids potentially associated with carotid intima-media thickness (CIMT).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES